- Advanced imaging and image-guided radiation therapy of head and neck malignancies
- Clinical trials of molecular targeted agents for head and neck cancer
- Radiation treatment planning and toxicity assessment
- Symptom assessment and supportive care
John N Waldron
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG...
Radiother Oncol. 2017 Nov 24;:
The Current State of Biological and Clinical Implications of Human Papillomavirus-Related Oropharyngeal Cancer.
Semin Radiat Oncol. 2018 Jan;28(1):17-26
Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer.
JAMA Otolaryngol Head Neck Surg. 2017 Nov 22;:
Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
J Clin Oncol. 2017 Oct 24;:JCO2017738633
Clinical outcomes of hypofractionated radiation therapy for choroidal metastases: Symptom palliation, tumor control, and survival.
Pract Radiat Oncol. 2017 Jun 29;:
Radiother Oncol. 2017 Aug;124(2):225-231
Oral Oncol. 2017 Sep;72:157-164
Brachytherapy. 2017 Jul 27;:
Lancet Oncol. 2017 Jul 27;:
Oral Oncol. 2017 Aug;71:113-121
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Assistant Professor, Departments of Radiation Oncology and Otolaryngology, University of Toronto
Head and Neck Site Group Leader, Radiation Medicine Program, University Health Network
Vice President, University Health Network Medical Staff Association